< Back to companies
Deargen (디어젠)

Deargen (디어젠)

Daejeon, South Korea

AI / MLPrecision Medicine/Diagnostics

DearGen is focused drug design and development using artificial intelligence. DearGen develops Dr. UG, an AI platform for target discovery based on deep learning technology. The company specializes in genome data analysis, biomarker prediction, molecule selection and optimization.

✓Source: HealthTech Alpha by Galen Growth
ShareLinkedInXFacebookRedditEmail
Only accessible to MedStartr community members. Join now

Company Info

Founded
2016
Website
deargen.me/

Categories

AI / MLPrecision Medicine/Diagnostics
🌐Website
Only accessible to MedStartr community members. Join now

What do you think of Deargen (디어젠)?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now